UNSPSC 51162404: Acetaminophen/dextromethorphan/guaifenesin/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE514. This VA Drug Class (RE514) classifies this compound as belonging to the group DECONGESTANT/ANTITUSSIVE/EXPECTORANT/ANALGESIC.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162404 Acetaminophen/dextromethorphan/guaifenesin/pseudoephedrine is a Commodity code covering over-the-counter combination cold and cough medications in tablet or capsule form. State and local governments procure this product primarily through multi-source pharmaceutical cooperative purchasing agreements serving public health departments, emergency response programs, and community health facilities. Recent solicitations show demand driven by opioid-crisis response initiatives and routine inventory replenishment across state and local health systems, with the work encompassing product supply, warehousing coordination through authorized pharmaceutical wholesalers, compliance with FDA and Drug Supply Chain Security Act requirements, and quarterly or as-needed delivery to specified facilities.

The most active issuing bodies are state health departments and cooperative purchasing alliances serving multi-state networks of counties and municipalities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, including Oregon, with products distributed through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, though this opportunity reflects opioid-response procurement rather than the acetaminophen/dextromethorphan combination scope. Geographic activity centers on Minnesota and Florida, with the MMCAP cooperative structure indicating broader multi-state participation.